<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>David Hinrichs | SynoSys</title>
    <link>https://synosys.github.io/authors/david/</link>
      <atom:link href="https://synosys.github.io/authors/david/index.xml" rel="self" type="application/rss+xml" />
    <description>David Hinrichs</description>
    <generator>Wowchemy (https://wowchemy.com)</generator><language>en-us</language><copyright>Â© 2024 Center Synergy of Systems</copyright><lastBuildDate>Tue, 25 Jul 2023 00:00:00 +0000</lastBuildDate>
    <image>
      <url>https://synosys.github.io/authors/david/avatar_hu199617708dd83969a5d0c8dc6d0e2c49_1359046_270x270_fill_q75_lanczos_center.jpg</url>
      <title>David Hinrichs</title>
      <link>https://synosys.github.io/authors/david/</link>
    </image>
    
    <item>
      <title>Evidence for positive long- and short-term effects of vaccinations against COVID-19 in wearable sensor metrics</title>
      <link>https://synosys.github.io/publication/wiedermann-2023-evidence/</link>
      <pubDate>Tue, 25 Jul 2023 00:00:00 +0000</pubDate>
      <guid>https://synosys.github.io/publication/wiedermann-2023-evidence/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Is testing at home sufficient? Self tests and official statistics</title>
      <link>https://synosys.github.io/old_news/datenspende_blog_incidence/</link>
      <pubDate>Wed, 10 Aug 2022 00:00:00 +0000</pubDate>
      <guid>https://synosys.github.io/old_news/datenspende_blog_incidence/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Evidence for positive long- and short-term effects of vaccinations against COVID-19 in wearable sensor metrics -- Insights from the German Corona Data Donation Project</title>
      <link>https://synosys.github.io/publication/wiedermann-2022-long_covid/</link>
      <pubDate>Wed, 06 Apr 2022 00:00:00 +0000</pubDate>
      <guid>https://synosys.github.io/publication/wiedermann-2022-long_covid/</guid>
      <description></description>
    </item>
    
    <item>
      <title>New preprint: Evidence for positive long- and short-term effects of vaccinations against COVID-19 in wearable sensor metrics -- Insights from the German Corona Data Donation Project</title>
      <link>https://synosys.github.io/old_news/long_covid_preprint/</link>
      <pubDate>Wed, 06 Apr 2022 00:00:00 +0000</pubDate>
      <guid>https://synosys.github.io/old_news/long_covid_preprint/</guid>
      <description>&lt;p&gt;In this paper we use physiological data collected in the &lt;a href=&#34;https://corona-datenspende.de/science/en/&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;German Data Donation Project (Datenspende)&lt;/a&gt; to investigate the differential impact of vaccination on the effect that a COVID-19 infection has on &lt;strong&gt;resting heart rate&lt;/strong&gt;, &lt;strong&gt;physical activity&lt;/strong&gt; and &lt;strong&gt;sleep&lt;/strong&gt;.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;The preprint is available here:&lt;/strong&gt; &lt;a href=&#34;https://arxiv.org/abs/2204.02846&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;https://arxiv.org/abs/2204.02846&lt;/a&gt;.&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>Potential benefits of delaying the second mRNA COVID-19 vaccine dose</title>
      <link>https://synosys.github.io/publication/maier-2021-potential/</link>
      <pubDate>Mon, 01 Mar 2021 00:00:00 +0000</pubDate>
      <guid>https://synosys.github.io/publication/maier-2021-potential/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Preprint out: Potential benefits of delaying the second mRNA COVID-19 vaccine dose</title>
      <link>https://synosys.github.io/old_news/vaccination_paper/</link>
      <pubDate>Mon, 01 Mar 2021 00:00:00 +0000</pubDate>
      <guid>https://synosys.github.io/old_news/vaccination_paper/</guid>
      <description>&lt;p&gt;We are happy that our preprint &lt;a href=&#34;https://arxiv.org/pdf/2102.13600.pdf&#34; target=&#34;_blank&#34; rel=&#34;noopener&#34;&gt;&lt;strong&gt;Potential benefits of delaying the second mRNA COVID-19 vaccine dose&lt;/strong&gt;&lt;/a&gt; is out and available on &lt;em&gt;arxiv.org&lt;/em&gt;.&lt;/p&gt;
&lt;p&gt;This has been a very constructive and effective collaborative effort, lead by our &lt;a href=&#34;https://synosys.github.io/author/dr.-benjamin-f.-maier/&#34;&gt;Ben Maier&lt;/a&gt;, who did all the heavy lifting, and valuable contributions by the teams of Cornelia Betsch, Michael Meyer-Hermann and by Karl Lauterbach.&lt;/p&gt;
&lt;p&gt;In a nutshell we evaluate and compare different vaccination strageties of COVID-19 mRNA-vaccines in high-risk groups in Germany and show that a flexible scheduling of the second vaccine dose can potentially be the way to go. If you are interested in the details, have a look at the manuscript.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Here&amp;rsquo;s the abstract:&lt;/strong&gt;&lt;/p&gt;
&lt;hr&gt;
&lt;p&gt;Vaccination against COVID-19 with the recently approved mRNA vaccines BNT162b2 (BioNTech/Pfizer) and mRNA-1273 (Moderna) is currently underway in a large number of countries. However, high incidence rates and rapidly spreading SARS-CoV-2 variants are concerning. In combination with acute supply deficits in Europe in early 2021, the question arises of whether stretching the vaccine, for instance by delaying the second dose, can make a significant contribution to preventing deaths, despite associated risks such as lower vaccine efficacy, the potential emergence of escape mutants, enhancement, waning immunity, reduced social acceptance of off-label vaccination, and liability shifts. A quantitative epidemiological assessment of risks and benefits of non-standard vaccination protocols remains elusive. To clarify the situation and to provide a quantitative epidemiological foundation we develop a stochastic epidemiological model that integrates specific vaccine rollout protocols into a risk-group structured infectious disease dynamical model. Using the situation and conditions in Germany as a reference system, we show that delaying the second vaccine dose is expected to prevent deaths in the four to five digit range, should the incidence resurge. We show that this considerable public health benefit relies on the fact that both mRNA vaccines provide substantial protection against severe COVID-19 and death beginning 12 to 14 days after the first dose. The benefits of protocol change are attenuated should vaccine compliance decrease substantially. To quantify the impact of protocol change on vaccination adherence we performed a large-scale online survey. We find that, in Germany, changing vaccination protocols may lead to small reductions in vaccination intention. In sum, we therefore expect the benefits of a strategy change to remain substantial and stable.&lt;/p&gt;
&lt;hr&gt;
</description>
    </item>
    
    <item>
      <title>Corona Datenspende App</title>
      <link>https://synosys.github.io/project/datenspende/</link>
      <pubDate>Thu, 14 Jan 2021 00:00:00 +0000</pubDate>
      <guid>https://synosys.github.io/project/datenspende/</guid>
      <description></description>
    </item>
    
    <item>
      <title>COVID-19 lockdown induces disease-mitigating structural changes in mobility networks</title>
      <link>https://synosys.github.io/publication/schlosser-2020-covid/</link>
      <pubDate>Fri, 03 Jul 2020 00:00:00 +0000</pubDate>
      <guid>https://synosys.github.io/publication/schlosser-2020-covid/</guid>
      <description></description>
    </item>
    
  </channel>
</rss>
